Author

Pablo Engel

Universitat de BarcelonaORCID 0000-0001-8410-252XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adela EscuderoiD· 1 shared Aïda FalgàsiD· 1 shared Alba Garcia-Perez· 1 shared Alba Martínez‐Moreno· 1 shared André BarucheliD· 1 shared Antonio Pérez-Martínez· 1 shared Apostol Apostolov· 1 shared Aurélie Caye‐EudeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adela EscuderoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia

Néstor Tirado, Klaudyna Fidyt, María José Mansilla, Alba Garcia-Perez, Alba Martínez‐Moreno, Meritxell Vinyoles, Juan Alcaín, Marina García-Peydró, Heleia Roca-Ho, Narcís Fernández‐Fuentes, Mercedes Guerrero-Murillo, Aïda Falgàs, Talía Velasco-Hernández, Clara Bueno, Patrizio Panelli, , Pablo R. Menéndez

This paper develops and validates a dual-targeting CAR-T cell therapy for T-ALL that targets CCR9 and CD1a, showing improved efficacy and safety compared to single-targeting approaches.

Journal of Hematology & Oncology · Jul 1, 2025Peer-reviewedImmunology